4//SEC Filing
Cerulean Pharma Inc. 4
Accession 0001209191-15-010884
$DARECIK 0001401914operating
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:07 PM ET
Size
5.5 KB
Accession
0001209191-15-010884
Insider Transaction Report
Form 4
GUIFFRE CHRISTOPHERD T
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2015-02-05+75,000→ 317,457 totalExercise: $8.16Exp: 2025-02-04→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 5, 2015. The option vests as to 2.08333% of the underlying shares monthly through and including February 5, 2019.
Documents
Issuer
Cerulean Pharma Inc.
CIK 0001401914
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001401914
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 5:07 PM ET
- Size
- 5.5 KB